Calcivis expands board to accelerate US growth

Edinburgh-based dental imaging pioneer Calcivis has appointed Heather Tombley and Simon Jackson as non-executive directors to bolster its commercialisation efforts in the US market.

Heather Tombley, president and chief operating officer of DentalEZ, brings over 20 years of experience in health and dental care with roles at GE Healthcare and ConMed Corporation. Based in Pennsylvania, she has a strong track record in launching medical devices in the US and fostering growth-driven cultures.

She said: “The US dental market is growing rapidly, and Calcivis’s technology can harness that growth to steer the market towards a more preventative approach. 

“I’m excited to join Calcivis and I’m looking forward to supporting Adam and the team to bring the product to market.” 

Simon Jackson, with 28 years in the medical device sector, has held leadership roles including chief executive of Frontier Medical Group. He currently serves in advisory positions with Inpress and Summit Medical Group.

He said: “Having led other medical device businesses and supported their international growth, I’m proud to be joining Calcivis as a non-executive director. 

“The company is in an exciting place and is well-positioned to maximise on the opportunities offered in the US market.”

Adam Christie, chief executive officer of Calcivis, added: “Heather and Simon have unrivalled experience within both the dental and medical instruments sector which will be incredibly beneficial in directing our US expansion strategy. 

“Our presence in the United States is growing, with a commercial team and now senior Non-Exec representation in that market. 

“Our device is user-friendly and market-ready, and we are confident that the Calcivis Imaging System will significantly improve patient care and enable restorative dentistry to move to a more preventive approach.”

The appointments follow a £5 million funding round led by the Scottish National Investment Bank, Maven and Archangels. Calcivis’s flagship CALCIVIS Imaging System, approved by the FDA, aims to transform dentistry by detecting early tooth decay using bioluminescence. 

With a newly opened US headquarters in Milton, Massachusetts, Calcivis is well-positioned to tap into the growing US dental market. 

Sarah Hardy, head of new investments and director at Archangels, added: “Archangels has supported Calcivis since 2012, and these latest appointments underline the company’s scale of ambition and opportunity in the US market. 

“Calcivis’s novel imaging technology has the potential to revolutionise dentistry, moving away from a ‘drill and fill’ approach to a more preventative model – echoing wider medical trends.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →